| For: | de Moraes Andrade PV, Monteiro YM, Chehter EZ. Third-line and rescue therapy for refractory Helicobacter pylori infection: A systematic review. World J Gastroenterol 2023; 29(2): 390-409 [PMID: 36687120 DOI: 10.3748/wjg.v29.i2.390] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i2/390.htm |
| Number | Citing Articles |
| 1 |
Belén Martínez Benito, Olga P. Nyssen, Javier P. Gisbert. Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis. Helicobacter 2024; 29(6) doi: 10.1111/hel.13148
|
| 2 |
Canyu Zhan, Yurong Huang, Zhengyi Yang, Hua Wu, Juan Zheng, Wangliu Yang, Junjie Rao, Gengqing Song, Jie Yang. Novel non-antibiotic triple therapy for Helicobacter pylori-positive functional dyspepsia patients resistant to conventional antibiotic treatments: an exploratory pilot study. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1759043
|
| 3 |
Joseph Edwin Kanu, Jonathan Soldera. Treatment of <i>Helicobacter pylori</i> with potassium competitive acid blockers: A systematic review and meta-analysis. World Journal of Gastroenterology 2024; 30(9): 1213-1223 doi: 10.3748/wjg.v30.i9.1213
|
| 4 |
Mahmoud Ali Abdi. Efficacy of Levofloxacin and Metronidazole-Based Triple Therapy in Eradicating <i>Helicobacter pylori</i> in Patients with Chronic Recurrent Epigastric Pain: A Prospective Study in Zakho, Iraq. Archives of Clinical Infectious Diseases 2024; 20(1) doi: 10.5812/archcid-148888
|
| 5 |
Hideki Mori, Yoshimasa Saito, Hiroko Ando, Tatsuhiro Masaoka, Juntaro Matsuzaki, Masaru Nakano, Takanori Kanai. Third-Line and Later Susceptibility-Guided Helicobacter pylori Eradication Therapies: A Multicenter Study of Vonoprazan–Amoxicillin–Sitafloxacin/Rifabutin Regimens. Journal of Clinical Medicine 2026; 15(2) doi: 10.3390/jcm15020434
|
| 6 |
Thi Nhu Le Tran, Ngoc-Niem Bui, Vu Trung Nguyen, Ngoc Anh Tran. Novel DNA gyrase mutations in levofloxacin-resistant Helicobacter pylori isolates from southern Vietnam. Journal of Microbiology, Immunology and Infection 2025; 58(4) doi: 10.1016/j.jmii.2025.03.012
|
| 7 |
Claudiu T. Supuran.
Novel carbonic anhydrase inhibitors for the treatment of
Helicobacter pylori
infection
. Expert Opinion on Investigational Drugs 2024; 33(5) doi: 10.1080/13543784.2024.2334714
|
| 8 |
Maria Belen Justich, Olga L. Rojas, Alfonso Fasano. The Role of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Parkinson's Disease. Seminars in Neurology 2023; 43(04) doi: 10.1055/s-0043-1771468
|
| 9 |
Chia-Jung Kuo, Ngoc-Niem Bui, Jun-Nong Ke, Cheng-Yu Lin, Wey-Ran Lin, Ming-Ling Chang, Hui-Yu Wu, Mei-Zi Huang, Cheng-Hsun Chiu, Cheng-Tang Chiu, Chih-Ho Lai. Molecular characterization of rifabutin-resistance in refractory Helicobacter pylori infection in Taiwan. International Journal of Infectious Diseases 2024; 138 doi: 10.1016/j.ijid.2023.11.001
|
| 10 |
Luiz Gonzaga Vaz COELHO, Bruno Squárcio Fernandes SANCHES, Ismael MAGUILNIK, James Ramalho MARINHO, Sandro Rodrigues CHAVES, Ana Flávia P. RAMOS, Heinrich SEIDLER, Ricardo C. BARBUTI, Renato S. LABOISSIÈRE, Laércio Tenório RIBEIRO, Maria do Carmo F. PASSOS, Julio César de Soares VELOSO, Lucia Libanês C. BRAGA, Frederico Passos MARINHO, Helenice P. BREYER, Hoiti OKAMOTO, Jardel Soares CAETANO, Paulo Pimentel D’ASSUMPÇÃO, Leonardo Soares da SILVA, Gerson DOMINGUES, Raul Carlos WAHLE, Eliza Maria de BRITO, Marcela Tavares da Rocha LOURES, Joaquim Prado MORAES-FILHO, Décio CHINZON, Áureo Almeida DELGADO. VTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION. Arquivos de Gastroenterologia 2026; 63 doi: 10.1590/s0004-2803.24612026-043
|
| 11 |
William D. Chey, Colin W. Howden, Steven F. Moss, Douglas R. Morgan, Katarina B. Greer, Shilpa Grover, Shailja C. Shah. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology 2024; 119(9) doi: 10.14309/ajg.0000000000002968
|
| 12 |
R. Dertli, M. Asıl, Y. Atayan, U. Coşar, R. Yolaçan, M. Bıyık, M. Keskin. Bismuth-Based quintuple therapy: a step beyond quadruple regimens in H. Pylori treatment and the impact of patient compliance. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04417-6
|
| 13 |
Jun-Hyung Cho, So-Young Jin.
Diagnosis and treatment of
Helicobacter pylori
infection: past, present, and future
. Future Microbiology 2025; 20(13) doi: 10.1080/17460913.2025.2568326
|
| 14 |
Maria Pina Dore, Elettra Merola, Giovanni Mario Pes. Advances and future perspectives in the pharmacological treatment of Helicobacter pylori infection: Taking advantage from artificial intelligence. Clinics and Research in Hepatology and Gastroenterology 2025; 49(9) doi: 10.1016/j.clinre.2025.102689
|